Neutral Physics Corporation

Neutral Physics is a biotechnology company that leverages advanced physics-based simulations to accelerate the discovery of novel small molecule therapeutics. The company's platform utilizes high-fidelity molecular dynamics and quantum mechanics to predict molecular interactions with high precision, specifically targeting "hard-to-drug" proteins. By integrating fundamental physical principles with machine learning, Neutral Physics aims to design drugs with superior binding affinity and selectivity compared to traditional methods. The company focuses on high-value therapeutic areas, including oncology and immunology, where structural complexity has historically hindered drug development. Neutral Physics is headquartered in Tel Aviv and is backed by prominent venture capital firms such as Pitango HealthTech.